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Summary 
Phosphatidate phosphohydrolase (EC 3.1.3.4) activity can be found in late 
gestational human amniotic fluid and is thought to originate in type II alveolar 
cells of the fetal lungs where it plays an important role in lung surfactant 
synthesis. In the present study, phosphatidate phosphohydrolase activity was 
detected and characterized in a 105 000 X g pellet of amniotic fluid using either 
[ 32P]phosphatidate or a water-soluble analog, 1-0-hexadecyl-rut-[ 2-‘HIglycerol 
3-phosphate as substrate. With either substrate, enzyme activity was optimal 
at pH 6.0. The soluble analog was hydrolyzed with a K, value of 163 PM and a 
V of 30 nmol/min per mg of protein, and offered several advantages over phos- 
phatidate as a substrate for assaying phosphatidate phosphohydrolase in 
amniotic fluid. Using the synthetic analog, phosphatidate phosphohydrolase 
activity was measured in the 700 Xg supernatant fraction of 30 human 
amniocentesis samples and compared with another index of fetal lung maturity, 
the phosphatidylcholine/sphingomyelin ratio. The results suggest that the new 
phosphohydrolase assay may be clinically useful in the assessment of fetal lung 
development. 
Introduction 
Because of its role in facilitation of gas transport, the lung alveolus is 
inherently a delicate and unstable structure. The tendency to collapse is 
counteracted by a lipoprotein surfactant which reduces alveolar surface 
tension. Dipalmitoyl phosphatidylcholine is the phospholipid present in 
greatest amounts in the pulmonary surfactant and is believed to be largely 
responsible for the observed surface-active properties [l]. During fetal lung 
development, the surfactant is found in the amniotic fluid in increasing 
Abbreviation: l-alkylglycerol-3-P. 1-0-hexadecyl-rat-glycerol 3-phosphate 
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amounts and its measurement has been used to assess fetal lung maturity in the 
prevention of respiratory distress syndrome of the newborn [Z---5]. In 
pregnancies in which the extent of fetal lung development must be determined, 
measurement of the phosphatidylcholine~sphingomyelin ratio in amniotic fluid 
has become an accepted procedure [ 21. 
The biosynthesis of pulmonary surfactant phosphatidylcholine has received 
considerable attention, and in most species the major pathway appears to 
proceed via CDPcholine [6]. Several studies have sought to identify an enzyme 
regulating dipalmitoyl phosphatidylcholine synthesis in fetal lung. The 
activities of most of the enzymes in the biosynthetic pathway either remain 
largely unchanged throughout gestation, or else change in a manner difficult to 
relate to the observed prenatal surge in surfa~tant phosphatidylcholine 
synthesis [ 7-111. However, the activities of lysophosphatidylcholine : lyso- 
phosphatidylcholine acyltransferase in mouse lung and phosphatidate phospho- 
hydrolase in rabbit lung have been shown to increase dramatically prior to the 
detectable initiation of surfactant synthesis [12,13]: Furthermore, phos- 
phatidate phosphohydrolase appears to be secreted along with the surfactant 
and its presence can be detected in human amniotic fluid [ 141. This enzyme 
has been extensively studied in other tissues. In liver, there is evidence that it 
may be the rate-limiting enzyme m the synthesis of both neutral lipid [ 151 and 
glycerophospholipid [ 161. It is not unreasonable therefore to suspect that 
phosphatidate phosphohydrolase plays a role in regulating surfactant phos- 
phatidylcholine synthesis. 
Johnston and co-workers [ 141 have described the relationship between levels 
of phosphatidate phosphohydrolase and the phosphatidylcholine/sphingomyelin 
ratio in amniotic fluid and have suggested that measurement of amniotic phos- 
phatidate phosphohydrolase may be useful for evaluating fetal lung maturation 
{ 141, However, despite the considerable interest in phosphatidate phospho- 
hydrolase, there has not been a convenient, sensitive assay for this enzyme. In a 
recent study of phosphatidate phosphohydrolase in guinea-pig brain [17] we 
found lysophosphatidate (I-acylglycerol 3-phosphate) to be a good substrate 
for the enzyme and a sensitive assay was developed utilizing 1-alkyl-[2-3H]- 
glycerol 3-phosphate as substrate [S]. In the present study we describe the 
application of this assay to human amniotic fluid phosphatidate phospho- 
hydrolase and examine its usefulness as a possible clinical assay for the enzyme. 
Materials and Methods 
Samples of amniotic fluid were taken by amniocentesis for routine clinical 
analysis and portions remaining were kindly made available by Dr. K.M.J. 
Menon, Department of Obstetrics and Gynecology, University of Michigan. To 
remove cont~ination by intact cells and debris, amniotic fluid samples were 
centrifuged at 700 X g for 5 min at 4°C and the pellet was discarded. In experi- 
ments in which the relationship between phosphatidate phosphohydrolase 
activity and the phosphatidylcholine/sphingomyelin ratio was investigated, the 
700 Xg supernatant was used directly. When ch~acte~stics of the enzyme in 
amniotic fluid were investigated (see Figs. 1, 2 and 3), a further centrifugation 
at 105 000 X g for 60 min was performed [ 131. Samples of amniotic fluid (6-8 
333 
of gestational age 34-38 weeks) were routinely pooled. The combined sample 
was centrifuged at 105 000 X g for 60 min. The pellet was resuspended in water 
using a glass-glass homogenizer. 
Acid phosphatase (potato B grade) was obtained from Calbiochem, Los 
Angeles, Calif. Alkaline phosphatase (calf intestine Type VII), chimyl alcohol, 
hexadecyl iodide, p-nitrophenylphosphate and tris(hydroxymethyl)amino- 
methane (Trizma Base) were from Sigma Chemical Co., St. Louis, MO. 2- 
Amino-2-methyl-propan-l-01 was supplied by Eastman Organic Chemicals, 
Rochester, N.Y. Bovine serum albumin Pentex@, was purchased from Miles 
Labs., Inc., Elkhart, Ind. Sodium boro [3H]hydride (NaB3H4, 8 Ci/mmol) was 
supplied by Amersham/Searle Corp., Arlington Heights, Ill. Other chemicals 
were of commercially available reagent grade, 
Preparation of 1 -O-hexadecyE-rac-[2-3H]glycero1 3-phosphate. l-0-Hexadecyl 
dihydroxyacetone 3-phosphate was synthesized as outlined by Hajra [ 191, 
except that the intermediate 2-0-hexadecyl glycolic acid was synthesized by 
refluxing hexadecyl iodide, ethyl glycolate and Ag,O in a molar ratio of 1 : 
2.5 : 1.5 in xylene for 15 h. 1-0-Hexadecyl-rat-[ 2-3H]glycerol 3-phosphate (l- 
alkylglycerol 3-P) was prepared from 1-0-hexadecyl dihydroxyacetone phos- 
phate by reducing with NaB3H4 [ 201. The product was purified by column 
chromatography (Unisil, Clarkson Chemical Co., Inc., Williamsport, Pa). Non- 
polar contaminants were eluted with three column volumes of chloroform 
followed by five column volumes of chloroform/methanol (4 : 1, v/v) to elute 
l-alkylglycerol-3-P. Purity of the substrate was assessed by thin-layer 
chromatography on silica gel G plates (Uniplate, Analtech Inc., Newark, Del.) 
developed in chloroform/methanol/acetic acid/water (100 : 40 : 12 : 4, v/v) 
followed by fluorography [21]. Specific radioactivity of the substrate was 
determined using the phosphate assay of Ames and Dubin [22] and measuring 
radioactivity in an ethanol/toluene scintillant (200 ml ethanol, 3640 ml 
toluene, 20 g PPO and 0.4 g POPOP). The purified substrate was stored in 
chloroform/methanol (2 : 1, v/v) at -20°C. 
Preparation of [32P]phosphatidate. The preparation of membrane-bound 
[32P]phosphatidate is described elsewhere [ 171. In preliminary experiments it 
was observed that phosphatidate in this form was not a good substrate for 
amniotic fluid phosphatidate phosphohydrolase. However, aqueous dispersions 
of [32P]phosphatidate were much more rapidly hydrolyzed by the enzyme. 
Total lipid was extracted from [ 32P]phosphatidate-enriched microsomes using 
an acidic extraction procedure [23]. Most of the radioactivity (>95%) was 
recovered in phosphatidate. Small amounts of the total lipid extract were 
mixed with purified unlabelled phosphatidate prepared from egg phosphatidyl- 
choline [24,25], and this mixture was used to prepare aqueous dispersions of 
substrate. 
Assay of phosphatidate phosphohydrolase. (1) [32P]Phosphatidate as 
substrate: In some experiments the characteristics of l-alkylglycerol-3-P and 
[32P] phosphatidate hydrolysis by phosphatidate phosphohydrolase were com- 
pared. Aqueous dispersions of [ 32P]phosphatidate were prepared by sonicating 
in 70 mM Tris/maleate buffer (pH 6.0) for 60 s (Bransonic 2, 60Hz-40W, Heat 
Systems-Ultrasonics Inc., Plainview, N.Y.). Assays were performed at 37°C for 
60 min and contained 3.5 pmol of Tris/maleate buffer (pH 6.0), 0.54 pmol of 
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E3’P]phosphatidate (approx. 0.08 Cilmol) and amniotic fluid 105 000 Xg 
pellet (50-150 pg protein) in a total volume of 100 ~1. Incubations were 
started by the addition of enzyme and terminated by mixing with 1.1 ml of 
chloroform/methanol (1 : 2, v/v). After adding 0.6 ml of 0.1 M HCl and 0.6 ml 
of chloroform, samples were again vortex-mixed and then centrifuged (700 X g 
for 5 min). An aliquot (0.8 ml) of the upper phase was added to 9 ml of Triton 
scintillant (780 ml of Triton X-100, 2100 ml of toluene, 15 g PPO and 0.3 g 
POPOP) and radioactivity determined. 
(2) 1-0-Hexadecyl [2-3H]glycerol 3-phosphate as substrate: Suspensions of 
1-alkylglycerol-3-P (1 mM) were prepared by warming the lipid to 40°C in 
70 mM Tris/maleate buffer (pH 6.0) and sonicating briefly (3 X 20 s). Incuba- 
tions were at 37°C in a shaking water bath and contained in a final volume of 
100 ~1, 3.5 pmol Tris/maleate buffer (pH 6.0), 50 nmol 1-alkylglycerol-3-P 
(approx. 20 Ci/mol) and phosphatidate phosphohydrolase (5-100 pg protein). 
When the enzyme activity was measured in amniotic fluid-700 X g supernatant, 
EDTA and bovine serum albumin were also included in the assay medium at 
final concentrations of 5 mM and 5 mg/ml, respectively. Unless otherwise 
stated, incubations were started by the addition of substrate and were for 
20 min. To terminate incubations, 1.4 ml ice-cold 20 mM NaOH and 2.0 ml ice- 
cold diethyl ether/ethanol (3 : 1, v/v) were added. After vortex-mixing (10 s) 
and centrifugation (700 X g for 1 min) a sample (1.0 ml) of the upper phase 
was dried in a scintillation vial and 10 ml ethanol/toluene scintillant were 
added. 
Other methods. Acid phosphatase was assayed in sodium citrate buffer 
(100 mM, pH 5.6) at 37°C using p-nitrophenylphosphate as substrate [26]. 
With the same substrate, alkaline phosphatase was determined at 25°C in 
150 mM 2-amino-2-me~yl-props-l-01 buffer (pH 10.0)/1.5 mM MgCl, by 
recording the increase in absorbance at 405 nm [27], Protein was determined 
by the method of Lowry et al. [28], with bovine serum albumin as standard. 
Phosphatidyl~holine~sphingomyelin ratios were determined as described by 
Bryson et al. [ 291. 
Results 
We have reported elsewhere the value of l-alkylglycerol-3-P as a substrate for 
a purified preparation of the soluble form of brain phosphatidate phospho- 
hydrolase [ 181. When this assay was applied directly to either whole amniotic 
fluid or the 700 Xg supernat~t, unexpectedly low phosphohydrolase levels 
were measured. In preliminary studies we found, as did Jimenez et al. [14], 
using phosphatidate as substrate, much higher levels of the phosphohydrolase 
in amniotic fluid by examining a 105 000 Xg pellet. Therefore, we first 
established optimal assay conditions using a 105 000 Xg pellet and then 
developed a suitable method for the low-speed supernatant fraction. 
Dependence of phosphatidate phosphohydrolase activity on pH 
Fig. 1 shows the effect of pH on phosphatidate phosphohydrolase in a 
105 000 X g pellet using either aqueous dispersions of phosphatidate or l-alkyl- 
glycerol-3-P as substrate. The observed optimum at pH 6.0 agrees with earlier 
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Fig. 1. The effect of pH on phosphatidate phosphohydrolase activity. Enzyme activity was measured in 
the amniotic fluid-105 000 X g pellet using either [ 32Plphosphatidate (9.0). or l-alkyl-[2-3H]glycerol-3-P 
(*,o) as substrate. Assay conditions were at 37’C for 20 min as described in the text. The buffers used 
were, 35mM Trislmaleate (m,*, PH 5.2-8.3) and 40mM 2-amino-2-methyl-propan-l-01 (o,o, pH 8.3- 
10.5). Values are means of three determinations. 
Fig. 2. The dependence of phosphatidate phosphohydrolase activity on 1-alkylglycerol-3-P concentration. 
The assays employed the 105 000 X g pellet from six pooled amniotic fluid samples. Different substrate 
concentrations were achieved by adding varying amounts of 1.5 mM l-alkyl-[2-3H]glycerol-3-P in 70 mM 
Tris/maleate buffer (PH 6.0). Other assay conditions were as described in the text. The data are from 
three experiments. 
work [ 141. A secondary peak of activity was observed at pH 9.5 when l-alkyl- 
glycerol-3-P was the substrate. This may represent activity of alkaline phos- 
phatase which is known to be present in amniotic fluid [30]. Using a’variety of 
criteria Jimenez et al. [14] were able to show that the hydrolysis of phos- 
phatidate by amniotic fluid is not attributable to alkaline phosphatase. How- 
ever, since 1-alkylglycerol-3-P is much more water soluble than phosphatidate 
and because of the known broad specificity of alkaline phosphatase, the 
possible interference by alkaline phosphatase with the present assay for phos- 
phatidate phosphohydrolase was examined (see below). 
Effect of 1 alkylglycerol-3-P concentration on phosphatidate phosphohydrolase 
The dependence of phosphatidate phosphohydrolase activity on l-alkyl- 
glycerol-3-P concentration is shown in Fig. 2. A reciprocal plot of the data 
shown yields a K, value of 163 FM and a V 30 nmol/min per mg protein. 
Similar experiments (not shown) using phosphatidate as substrate gave a K, 
value of approx. 4.5 mM. The continued rise in activity at concentrations of l- 
alkylglycerol-3-P above 1 mM may reflect the detergent properties of this 
substrate. Since phosphatidate phosphohydrolase in amniotic fluid is believed 
to be associated with lamellar bodies [ 131, high concentrations of l-alkyl- 
glycerol-3-P may cause release of sequestered enzyme from these structures. 
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Alternatively, the continued rise in activity may be the result of preference by 
the enzyme for the micellar form of the substrate analog. Routinely, the assay 
medium for the 105 000 Xg pellet contained 35 mM Tris/maleate buffer 
(pH 6.0) and 0.5 mM 1-alkylglycerol-3-P. The assay was linear with time for at 
least 60 min and with protein concentration up to 2 mg/ml. 
Heat denaturation of phosphatidate phosphohydrolase 
Fig. 3 shows that the rate of disappearance of l-alkylglycerol-3-P phos- 
phohydrolase activity closely parallels loss of phosphatidate phosphohydrolase 
activity during heat denaturation. This suggests that both substrates are 
hydrolyzed by the same enzyme(s). The data, plotted as log percent activity 
remaining against time at 70°C (see inset), indicate that the process is not first 
order, and suggest the presence of more than one enzyme or of different forms 
of the same enzyme. This heat stability was unexpected in view of studies of 
the same enzyme in other tissues [ 15,171. It was suspected that this could be in 
some way related to the association of the amniotic fluid enzyme with lamellar 
bodies. However, when we prepared lamellar body-free microsomes from adult 
rat lung essentially as described for pig lung by Spitzer et al. [ 311, microsomal 
phosphatidate phosphohydrolase was also relatively heat stable (45% activity 
remaining after 15 min at 70°C). It is possible that there is a difference between 
lung phosphatidate phosphohydrolase and forms from other tissues. 
0 4 8 12 16 
Time at 70°C (min) 
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Fig. 3. The heat-denaturation of phosphatidate phosphohydrolase. Aliquots of amniotic fluid-105 000 X g 
pellet were sealed in assay tubes and heated for different lengths of time at 70°C in a metal block. After 
heating, each tube was placed on ice for 5 min before centrifuging (700 X g for 6 min). While there was no 
actual sedimentation of the preparation, heating did increase turbidity. Assays were started by the addi- 
tion of either 1-alkyl-[2-3H]glycerol-3-P (0) or [ 3*P]phosphatidate (0) and were conducted as described 
in Materials and Methods. Mean of four determinations. 
Fig. 4. The effect of EDTA on l-alkylglycerol-3-P hydrolysis by amniotic fluid-700 X g suPernatant. The 
data shown are the means of four experiments with 700 X g supematant from four pooled samples of 
amniotic fluid. Varying amounts of disodium EDTA in 70 mM Tris/msleate buffer (PH 6.0) were added 
to the assay medium described in the text, in the presence (0) of 5 mg bovine serum albumin/ml. 0, 
represents activity in the absence of both EDTA and albumin (see text). 
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Measurement of phosphatidate phosphohydrolase in amniotic fluid-700 X g 
superna tan t 
Table I, in agreement with earlier work [ 131, demonstrates that most of the 
phosphatidate phosphohydrolase activity of amniotic fluid is membrane bound. 
In preparing the 105 000 X g pellet from amniotic fluid-700 X g supernatant, 
the specific activity of phosphatidate phosphohydrolase (1-alkylglycerol-3-P as 
substrate) was increased approx. 40-fold (Table I). However, recovery of 
activity at this step was about 215%, indicating activation (or release of inhibi- 
tion) of the enzyme. The 105 000 Xg supernatant was found to have very little 
phosphatidate phosphohydrolase activity, and when added back to the 
105 000 X g pellet, it produced a pronounced inhibition. The same supernatant 
also inhibited purified phosphatidate phosphohydrolase from rat liver prepared 
as described by Lamb and Fallon [ 151. The inhibitory factor was heat stable, 
dialyzable and could be accounted for by the reported high concentration of 
Mg2+ in amniotic fluid (0.4 mM) [32]. Inhibition could be overcome by the 
addition of 3 mM EDTA to the 105 000 X g supernatant fraction. The activity 
in the 105 000 Xg pellet was unaffected by EDTA. When EDTA was added to 
amniotic fluid-700 X g supernatant, 1-alkylglycerol-3-P hydrolysis was greatly 
increased (Figs. 4 and 5A). Bovine serum albumin also stimulated enzyme 
activity in this fraction (Fig. 5A), but was without effect on the 105 000 Xg 
pellet. The highest activity in the 700 Xg supernatant could be obtained with 
3 mM EDTA in the absence of albumin, but in this case poor linearity with 
both time and protein concentration was observed. Therefore, for the 700 Xg 
supernatant, the assay medium routinely contained 3.5 pmol of Tris/maleate 
buffer (pH 6.0), 50 nmol of l-alkyl-[2-3H]glycerol-3-P (approx. 20 Ci/mol), 
0.5 pmol of EDTA and 0.5 mg of bovine serum albumin, in a total volume of 
100 ~1. Under these conditions the assay was linear (Fig. 5B), and it was 
possible to determine phosphatidate phosphohydrolase activity in as little as 
10 ~1 of amniotic fluid-700 X g supernatant. 
TABLE I 
THE DISTRIBUTION OF PROTEIN AND PHOSPHATIDATE PHOSPHOHYDROLASE IN HUMAN 
AMNIOTIC FLUID 
Assays of phosphatidate phosphohydrolase were performed in 35 mM Tris/maleate buffer (PH 6.0) con- 
taining 0.5 mM l-alkyl-[2-3H]glycerol-3-P (15 pCi/mol) and 65 pg protein, in the absence of EDTA and 
bovine serum albumin. Incubations were for 20 min. The results shown are from a typical experiment. 
Absolute values vary with the gestational age of the amniotic fluid. n.d., not determined. 
Fraction Phosphohydrolase activity 
nmol 1-aIkylglycerol/ 






Whole amniotic fluid 0.29 
700 X g supematant 0.26 
700 X g pellet n.d. 
105 000 X g supematant 0.06 
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Fig. 5. (A) The dependence of 1-alkylglycerol-3-P hydrolysis on protein concentration. Three assay 
svstems are compared. In the first (0). the assay consisted of 3.5 pm01 Tris/meleate buffer (PH 6.0). 
50 nmol l-slkyl-[2-3H]glycerol-3-P (20 Ci/mol) and amniotic fluid-700 X g supernatant (80 pg protein). 
The second medium (0) contained in addition, bovine serum albumin (5 me/ml), while the third (A) 
included both albumin (5 mg/ml) and EDTA (5 mM). Incubations were for 46 min. Mean of three 
determinations. (B) The time course of l-alkylglycerol-3-P hydrolysis by amniotic fluid-700 X g super- 
natant. Assays were at 37OC for the times indicated and contained, 3.5 pmol Tris/meleate buffer (PH 6.0), 
50 nmol lalkyl-[2-3H]glycerol-3-P (20 Ci/mol), 0.5 pmol EDTA, 0.5 mg bovine serum albumin and 
amniotic fluid-700 X g supematent (65 pg protein) in a total volume of 100 ~1. Mean of six determina- 
tions. 
Contribution of acid and alkaline phosphatases to 1 alkylglycerol-3-P hydrolysis 
In an attempt to determine the specificity of the assay procedure, the ability 
of non-specific phosphatases to hydrolyze 1-alkylglycerol-3-P was investigated. 
At pH 5.6, the 700 Xg supernatant showed little activity with p-nitrophenyl- 
phosphate as substrate and conversely purified acid phosphatase from potato 
did not hydrolyze 1-alkylglycerol-3-P (Table II). This result, combined with the 
observed optimum at pH 6.0, argues against l-alkylglycerol-3-P hydrolysis by 
amniotic fluid being attributable to acid phosphatase. At pH 10.0, both the 
700 X g supernatant and the 105 000 X g pellet rapidly hydrolyzed p-nitro- 
TABLE II 
THE ESTIMATION OF ACID AND ALKALINE PHOSPHATASES IN HUMAN AMNIOTIC FLUID 
The results shown are the means of three determinations performed on a 700 Xg supernatant prepared 
from three pooled amniotic fluids (mean phosphatidylcholine/sphingomyelin = 1.8). Assays were 
described in the text using the following buffers; 100 mM sodium citrate (PH 5.6). 35 mM Tris/maleate 
(PH 6.0). 40 mM 2-amino-2-methyl-propan-l-01 (pH 9.5) and 150 mM 2-amino-2-methyl-propen-l-01 (PH 
10.0). n.d.. not determined. 
Enzyme system Enzyme activity (nmol/min with 
mg per protein) 
l-alkyl- p-Nitrophenyl- 
glycerol-3-P phosphate 
Acid phosphatase (potato), pH 5.6 0 194 
Alkaline phosphatase (calf intestine), pH 10.0 20 250 600 000 
Alkaline phosphatase (calf intestine), pH 10.0 + 5 mM EDTA 0 13 500 
700 X g supematant, pH 5.6 0.07 10.05 
700 X g supernatant, pH 6.0 0.08 n.d. 
700 X g supematant, pH 6.0, + 5 mM EDTA 0.66 n.d. 
700 X g supematant, pH 9.5 0.02 8.3 
700 X g supematant, pH 9.5, + 5 mM EDTA 0.18 1.6 
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phenylphosphate, indicating the presence of significant amounts of alkaline 
phosphatase (Table II). However, a number of observations suggest that it is 
not alkaline phosphatase which is responsible for 1-alkylglycerol-3-P hydrolysis 
by amniotic fluid at pH 6.0. First of all, the rate of hydrolysis of l-alkyl- 
glycerol-3-P at pH 9.5 is only 45% of that at pH 6.0 (Fig. 1). Secondly, with 
purified alkaline phosphatase from calf intestine, 1-alkylglycerol-3-P, is a 
relatively poor substrate compared with p-nitrophenylphosphate (Table II). 
Finally, while calf intestine alkaline phosphatase with either p-nitrophenyl- 
phosphate or 1-alkylglycerol-3-P as substrate is greatly inhibited by 5 mM 
EDTA, for amniotic fluid only p-nitrophenylphosphate hydrolysis is inhibited. 
l-Alkylglycerol-3-P hydrolysis is stimulated by the same concentration of 
EDTA at either pH 6.0 or pH 9.5 (Table II, Fig. 4). 
Relationship between l-alkylglycerol-3-P hydrolysis by amniotic fluid and the 
phosphatidylcholine/sphingomyelin ratio 
Johnston and co-workers [ 141 have described the relationship between phos- 
phatidate phosphohydrolase and the phosphatidylcholine/sphingomyelin ratio 
in amniotic fluid during gestation. Experiments here were undertaken to deter- 
mine if the assay procedure described above, using 1-alkylglycerol-3-P, could 
form the basis of a rapid, sensitive clinical assay for phosphatidate phospho- 
hydrolase in amniotic fluid. It was of particular interest to see how l-alkyl- 
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Fig. 6. The relationship between phosphatidate phosphohydrolase and the phosphatidylcholine/sphingo- 
my&n ratio of amniotic fluid. Enzyme activity was measured in 700 X g supernatants. using l-alkyl- 
glycerol-3-P as substrate in the presence of bovine serum albumin (5 mg/ml) and EDTA (5 mM) as 
described under Materials and Methods. Data points from samples of amniotic fluid taken at different 
times from the same patient are joined by lines. Values are means of duplicate determinations. (0, non- 
diabetics: 0, type B or C diabetics). 
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myelin ratio was in the region of 2.0. This ratio has been used widely as the 
lower limit when predicting fetal lung maturity. The data in Fig. 6 were 
obtained using 700 X g supernatant fractions of a series of amniotic fluids. In 
general, each patient contributed one sample of amniotic fluid. Where serial 
samples were taken from the same patient, these data points are joined by lines. 
The results indicate a positive correlation between l-alkylglycerol-3-P 
hydrolysis and the phosphatidylcholine/sphingomyelin ratio. 
Discussion 
It has been shown that the prenatal surge in surfactant synthesis is preceded 
by increased levels of phosphatidate phosphohydrolase in the lung [ 91. Phos- 
phatidate phosphohydrolase appears to be secreted into the lung alveoli along 
with the surfactant in the form of lamellar bodies and is found in increasing 
amounts in amniotic fluid as gestation proceeds [14]. In amniotic fluid, the 
enzyme is probably still associated with lamellar bodies [ 13,311. Jimenez and 
Johnston [13] have suggested that the measurement of amniotic fluid phos- 
phatidate phosphohydrolase may be a valid alternative to estimating the phos- 
phatidylcholine/sphingomyelin ratio for assessment of fetal lung development. 
In initial experiments, we found that in contrast with the brain enzyme, 
membrane-bound phosphatidate was not a good substrate for amniotic fluid 
phosphatidate phosphohydrolase and that hydrolysis of aqueous dispersions of 
phosphatidate proceeded with a low affinity but with velocities similar to those 
previously reported [ 141, A water-soluble substrate analog (1-alkylglycerol-3-P) 
has been used to develop a rapid, sensitive assay in guinea pig brain [ 181. The 
present study was undertaken to determine whether 1-alkylglycerol-3-P is 
suitable for a convenient clinical assay and for further characterization of 
amniotic fluid phosphatidate phosphohydrolase. 
By several criteria, hydrolysis of both the synthetic substrate (Table I) and 
phosphatidate [ 131 is attributable to the same enzyme(s) in amniotic fluid. The 
amniotic fluid-105 000 Xg pellet is enriched in both phosphohydrolase 
activities, and heat denaturation curves are superimposable. Using either 
substrate, the enzyme preparation was relatively heat resistant and the non- 
linearity of denaturation (inset, Fig. 3) suggested the presence of several 
catalytic proteins, one of which was heat stable. A heat-stable alkaline phos- 
phatase arising from trophoblast cells in the placenta has been detected in 
amniotic fluid [ 301, and the possibility that this accounted for the heat-stable 
component was investigated. The pH profile (Fig. l), however, showed an 
optimum at pH 6.0. The secondary peak at pH 9.5 is not explained but would 
be unlikely to contribute significantly to the assay at pH 6.0. It is difficult to 
attribute even the activity at pH 9.5 to alkaline phosphatase since, like 
hydrolysis at pH 6.0, it is stimulated by EDTA while alkaline phosphatase is 
inhibited by EDTA. Parenthetically, a further advantage of the synthetic analog 
is its alkaline stability. This not only permitted phosphatidate phospho- 
hydrolase activity measurement at high pH, but also facilitated quantitative 
extraction of the reaction product, neither of which was feasible using 
substrates with acyl groups. 
When phosphatidate phosphohydrolase was assayed in amniotic fluid-700 X 
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g supernatant using 1-alkylglycerol-3-P as substrate, enzyme activity was found 
to increase with the phosphatidylcholine~sph~ngomyelin ratio (Fig. 6) in agree- 
ment with earlier work in which phosphatidate was the substrate [35]. The 
exact relationship between these two clinically useful indicators of fetal lung 
maturation is unclear. If de novo synthesis of surfactant phosphatidylcholine 
in lung is limited by the av~lability of diacylglycerol, increased levels of phos- 
phatidate phosphohydrolase could result in an overall stimulation of this bio- 
synthetic pathway. It is thought that increased phosphatidate phospho- 
hydrolase activity in amniotic fluid toward the end of gestation reflects 
increased levels of this enzyme in type II alveolar epithelial cells in the lungs of 
the fetus. Lung surfactant is secreted from these cells in the form of lamellar 
bodies and phosphatidate phosphohydrolase has been shown histochemically 
to be associated with these structures [ 371. There is indirect evidence that the 
enzyme is secreted along with lamellar bodies and that fetal lung is the major 
source of amniotic fluid phosphatidate phosphohydrol~e [13]. Even though 
most of the increased phosphatidate phosphohydrolase in amniotic fluid 
appears to be due to increased secretion of the enzyme from fetal lungs, other 
causes of the increased activity cannot be ruled out. For example, the composi- 
tion of amniotic fluid is changing greatly over this period of gestation [ 381, and 
the removal of an inhibitor or appearance of an activator of phosphatidate 
phosphohydrolase could produce the same results. The concentration of phos- 
phatidylcholine rises from 3 to 9 mg/lOO ml during the period studied here 
[ 381, and its bearing on the measurement of phosphatidate phosphohydrolase 
was considered. We found, in fact, that added synthetic dip~mitoyl phos- 
phatidylcholine was somewhat stimulator-y, but could not account for the 
observed S-fold increase in phosphohydrolase activity (Fig. 6) even when 
50 mg/lOO ml were added, 
A number of pathological conditions are known to influence the phos- 
phatidyl~holine/sphingomyelin ratio and hamper evaluation of fetal lung 
development [38,39]. Of these conditions, maternal diabetes is of greatest 
clinical concern. Mild diabetes (Class B, C) delays both lung development and 
the increase in the phosphatidylcholine/sphingomyelin ratio [ 391. The 
preliminary studies reported here with the new assay indicate that these 
patients may have higher phosphatidate phosphohydrolase levels than non- 
diabetics with equivalent phosphatidylcholine/sphingomyelin ratios. When 
enzyme activity is plotted against gestational age, these patients again appear to 
have higher levels of enzyme at a particular time in gestation than do non- 
diabetics. This would suggest that the explanation for the delayed phosphatidyl- 
choline/sphingomyelin ratio in these patients does not lie in a deficiency of 
phosphatidate phosphohydrolase. 
It is not known at present whether the enzyme demonstrates varying 
affinities for the stereoisomers of phosphatidate, 1-acylglycerol-3-P, or I- 
alkylglycerol-3-P. We interpret the observed high V of the synthetic racemic 
analog to be largely due to its greater solubility than phosphatidate. This does 
not however explain its low K,, and raises the question of whether phos- 
phatidate is the true physiological substrate for the enzyme. Johnston et al. 
1401, have suggested that the substrate may be phosphatidylglycerol phos- 
phate. The enzyme then would catalyze the final reaction in the biosynthesis 
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of phosphatidylglycerol, a lipid which has recently received considerable 
attention as a component of lung surfactant [ 41-431. Regardless of the nature 
of the physiological substrate, the enzymic hydrolysis of l-alkylglycerol-3-P 
appears to be a useful indicator of fetal lung maturity, and it is hoped that the 
new assay described here will complement existing diagnostic procedures (44 3. 
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